A detailed history of Edgestream Partners, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Edgestream Partners, L.P. holds 8,344 shares of LLY stock, worth $6.23 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
8,344
Previous 13,387 37.67%
Holding current value
$6.23 Million
Previous $12.1 Million 39.01%
% of portfolio
0.33%
Previous 0.59%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $3.89 Million - $4.84 Million
-5,043 Reduced 37.67%
8,344 $7.39 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $5.83 Million - $7.31 Million
8,039 Added 150.32%
13,387 $12.1 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $384,337 - $514,189
649 Added 13.81%
5,348 $4.16 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $1.28 Million - $1.51 Million
2,434 Added 107.46%
4,699 $2.74 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $4.07 Million - $5.61 Million
-9,361 Reduced 80.52%
2,265 $1.22 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $430,007 - $574,969
1,226 Added 11.79%
11,626 $5.45 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $1.55 Million - $1.82 Million
4,988 Added 92.17%
10,400 $3.57 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $650,817 - $758,332
2,024 Added 59.74%
5,412 $1.98 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $5.51 Million - $6.27 Million
-18,571 Reduced 84.57%
3,388 $1.1 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $704,350 - $827,011
-2,527 Reduced 10.32%
21,959 $7.12 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $4.6 Million - $5.71 Million
19,588 Added 399.92%
24,486 $7.01 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $8.92 Million - $11.1 Million
-39,692 Reduced 89.02%
4,898 $1.35 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $707,125 - $870,217
-3,191 Reduced 6.68%
44,590 $10.3 Million
Q2 2021

Aug 10, 2021

BUY
$180.55 - $233.54 $6.96 Million - $9 Million
38,536 Added 416.83%
47,781 $11 Million
Q1 2021

May 06, 2021

BUY
$164.32 - $212.72 $1.52 Million - $1.97 Million
9,245 New
9,245 $1.73 Million
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $303,580 - $401,710
-2,327 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $340,253 - $393,565
2,327 New
2,327 $344,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $4.19 Million - $5.19 Million
-39,224 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $13.5 Million - $14.7 Million
-126,674 Reduced 76.36%
39,224 $4.39 Million
Q2 2019

Aug 08, 2019

BUY
$110.79 - $129.32 $10.7 Million - $12.5 Million
96,684 Added 139.69%
165,898 $18.4 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $7.7 Million - $9.07 Million
69,214 New
69,214 $8.98 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $188,419 - $222,416
-2,539 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $155,849 - $167,166
-1,902 Reduced 42.83%
2,539 $214,000
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $342,267 - $379,883
4,441
4,441 $380,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.